Pharyngeal spreading of peri-implant infections under antiresorptive/antiangiogenic therapy

Pharyngeal spreading of peri-implant infections under antiresorptive/antiangiogenic therapy

Abstract Objectives To assess the influence of antiresorptive/antiangiogenic therapy on the spreading of peri-implant infections in the pharyngeal region. Material and methods This analysis was based on tissue biopsies obtained from a total of twenty-five albino rats having either received (1) amino...

Full description

Bibliographic Details
Main Authors:	Karsten Kern, Fania Lukmann, Karina Obreja, Sara Al-Maawi, Bellinghausen Carla, Shahram Ghanaati, Gernot Rohde, Robert Sader, Frank Schwarz
Format:	Article
Language:	English
Published:	SpringerOpen 2021-06-01
Series:	International Journal of Implant Dentistry
Subjects:	Animal experiment Peri-implant infections Antiresorptive/antiangiogenic therapy Immunohistochemistry CD68 antigen
Online Access:	https://doi.org/10.1186/s40729-021-00332-z

Similar Items

Medication-related osteonecrosis of the jaw: A review about etiology, risk factors, pathophysiology, and treatment
by: Sheetal Singar, et al.
Published: (2020-01-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update
by: Gianluca Tenore, et al.
Published: (2014-12-01)

Effectiveness of Antiresorptive Treatment on Formation of Nonvertebral Fracture in Old Age: A Retrospective Study
by: Hakan Tuna, et al.
Published: (2005-06-01)

The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy
by: Kincse Gyöngyvér, et al.
Published: (2012-12-01)

An observational study to assess back pain in patients with severe osteoporosis treated with teriparatide versus antiresorptives: An Indian subpopulation analysis
by: Harvinder Chhabra, et al.
Published: (2015-01-01)

Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women’s health practice
by: Cheung AM, et al.
Published: (2016-09-01)

Knowledge and clinical behavior on antiresorptive medications and osteonecrosis of the jaws: a cross-sectional study
by: Daniel Amaral Alves MARLIÉRE, et al.
Published: (2019-12-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review
by: Julian Woolley, et al.
Published: (2021-01-01)

The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review
by: Roberto Sacco, et al.
Published: (2021-01-01)

A Systematic Review of Oxygen Therapy for the Management of Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Roberto Sacco, et al.
Published: (2019-03-01)

Modern aspects of antiangiogenic therapy in ovarian cancer
by: A. A. Rumyantsev, et al.
Published: (2018-11-01)

Antiangiogenic Effect of Flavonoids and Chalcones: An Update
by: Ladislav Mirossay, et al.
Published: (2017-12-01)

Antiangiogenic Polyketides from Peperomia dindygulensis Miq.
by: Hong-Zhuan Chen, et al.
Published: (2012-04-01)

Assessment of peri-implant tissue dimensions following surgical therapy of advanced ligature-induced peri-implantitis defects
by: Ausra Ramanauskaite, et al.
Published: (2021-01-01)

Progress of Antiangiogenic Drug-induced Renal Injury
by: FENG Qingyan, et al.
Published: (2021-04-01)

Investigation of peri-implant tissue conditions and peri-implant tissue stability in implants placed with simultaneous augmentation procedure: a 3-year retrospective follow-up analysis of a newly developed bone level implant system
by: Jonas Lorenz, et al.
Published: (2017-09-01)

Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments
by: Alicia González, et al.
Published: (2021-06-01)

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
by: Clavreul A, et al.
Published: (2019-04-01)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage
by: Watanabe, Takuma
Published: (2021)

Photodynamic therapy – hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity
by: Nikola Plenagl, et al.
Published: (2019-01-01)

Use of Antiangiogenic Therapies in Pediatric Solid Tumors
by: Claudia Ollauri-Ibáñez, et al.
Published: (2021-01-01)

Intraoral localized methotrexate‐associated lymphoproliferative disorders concurrent with antiresorptive agent‐related osteonecrosis of the jaw: A case report and literature review
by: Masaki Minabe, et al.
Published: (2020-12-01)

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents
by: Saumil Datar, et al.
Published: (2020-12-01)

Mathematical investigation of antiangiogenic monotherapy effect on heterogeneous tumor progression
by: Maxim Borisovich Kuznetsov, et al.
Published: (2017-06-01)

Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
by: Wuzhen Chen, et al.
Published: (2021-07-01)

Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01)

Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy
by: Amit Kumar Rajora, et al.
Published: (2020-06-01)

Osteoporosis: Current review
by: Alok Chandra Agrawal, et al.
Published: (2014-01-01)

Treatment of adult brainstem glioma with combined antiangiogenic therapy: a case report and literature review
by: Yu D, et al.
Published: (2019-02-01)

Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
by: Raybould AL, et al.
Published: (2020-09-01)

Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
by: Bahare Zarrin, et al.
Published: (2017-01-01)

Isolation and identification of eurycomanone from akar pasak bumi (Eurycoma longifolia, Jack) and its antiangiogenic activity
by: Sugiyanto, et al.
Published: (2009-09-01)

In vitro evaluation of the antitumoral and antiangiogenic effects of extracts from Spondias mombin L. leaves
by: Cristina Rey-Blanes, et al.
Published: (2020-11-01)

Mathematical modeling of low invasive tumor growth with account of inactivation of vascular endothelial growth factor by antiangiogenic drug
by: A. V. Kolobov, et al.
Published: (2015-04-01)

Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine
by: Hashem O. Alsaab, et al.
Published: (2021-02-01)

MODERN IDEAS ABOUT THE COMBINATION OF RADIATION THERAPY WITH ANTIANGIOGENIC DRUGS IN THE TREATMENT OF PATIENTS WITH BRAIN METASTASES
by: O. I. Kit, et al.
Published: (2020-03-01)

Effects of microRNA regulation on antiangiogenic therapy resistance in non-small cell lung cancer
by: Chenxi Hu, et al.
Published: (2020-11-01)

O sitio arqueológico Peri-peri em Pernambuco
by: Gabriela Martín, et al.
Published: (1983-12-01)

The prevalence of peri-implant disease following immediate implant placement and loading: a cross-sectional analysis after 2 to 10 years
by: Puria Parvini, et al.
Published: (2020-10-01)